tirzepatide

Tirzepatide weight-loss  injection

Describe Tirzepatide and describe the workings of our program.
Tirzepatide injection is an agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor.

Weight loss from baseline to 40 treatment weeks revealed that tripeptide (5 mg, 10 mg, and 15 mg) provided at least 30%, 60%, and up to 95% more weight loss than semaglutide (1 mg).